Antibodies with enhanced antibodydependent cellular cytoxicity activity, methods of their production and use

Details for Australian Patent Application No. 2012201010 (hide)

Owner Genzyme Corporation GTC Biotherapeutics, Inc.

Inventors Schindler, Daniel; Meade, Harry M.; Edmunds, Timothy; McPherson, John

Agent Davies Collison Cave

Pub. Number AU-A-2012201010

Parent 2006304886

Filing date 21 February 2012

Wipo publication date 8 March 2012

International Classifications

C07K 16/04 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from milk

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201010

8 March 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201011-Device for manufacturing a foundation for a mass located at height, associated method and assembly of the device and a jack-up platform

2012201009-Media enabled advertising shopping cart system